Ulrike Baum

1.0k total citations
40 papers, 663 citations indexed

About

Ulrike Baum is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Ulrike Baum has authored 40 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 12 papers in Infectious Diseases and 10 papers in Health. Recurrent topics in Ulrike Baum's work include Influenza Virus Research Studies (13 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Vaccine Coverage and Hesitancy (10 papers). Ulrike Baum is often cited by papers focused on Influenza Virus Research Studies (13 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Vaccine Coverage and Hesitancy (10 papers). Ulrike Baum collaborates with scholars based in Finland, Germany and Sweden. Ulrike Baum's co-authors include Hanna Nohynek, K. E. Rehfuess, Tuija Leino, Jukka Jokinen, Eero Poukka, Kari Auranen, Jonas Sundman, Sangita Kulathinal, Ritva Syrjänen and Niina Ikonen and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Ulrike Baum

40 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrike Baum Finland 15 239 212 160 90 58 40 663
Lennert Slobbe Netherlands 9 353 1.5× 326 1.5× 22 0.1× 22 0.2× 13 0.2× 19 759
Marco Bo Italy 18 187 0.8× 73 0.3× 16 0.1× 86 1.0× 6 0.1× 45 827
James L. Stewart United States 15 165 0.7× 397 1.9× 63 0.4× 18 0.2× 52 0.9× 24 975
Meng Wu United States 11 42 0.2× 248 1.2× 46 0.3× 238 2.6× 17 0.3× 26 666
Audrey Lustig New Zealand 16 66 0.3× 129 0.6× 33 0.2× 20 0.2× 186 3.2× 34 570
Daniel Jackson United States 11 142 0.6× 40 0.2× 39 0.2× 11 0.1× 6 0.1× 20 610
Rebecca Rose United States 11 65 0.3× 96 0.5× 49 0.3× 35 0.4× 25 0.4× 17 315
Renato Mendes Coutinho Brazil 13 27 0.1× 154 0.7× 51 0.3× 25 0.3× 99 1.7× 33 558
Katie Frith Australia 13 109 0.5× 45 0.2× 26 0.2× 30 0.3× 2 0.0× 28 907

Countries citing papers authored by Ulrike Baum

Since Specialization
Citations

This map shows the geographic impact of Ulrike Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Baum more than expected).

Fields of papers citing papers by Ulrike Baum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Baum. The network helps show where Ulrike Baum may publish in the future.

Co-authorship network of co-authors of Ulrike Baum

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Baum. A scholar is included among the top collaborators of Ulrike Baum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Baum. Ulrike Baum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baum, Ulrike, Niina Ikonen, Oskari Luomala, et al.. (2025). Influenza Epidemiology in Finland During and After the COVID‐19 Pandemic: Surveillance Data Analysis (2019–2024). Influenza and Other Respiratory Viruses. 19(6). e70131–e70131. 1 indexed citations
2.
Poukka, Eero, Jori Perälä, Hanna Nohynek, et al.. (2024). Relative effectiveness of bivalent boosters against severe COVID-19 outcomes among people aged ≥ 65 years in Finland, September 2022 to August 2023. Eurosurveillance. 29(37). 6 indexed citations
3.
Stuurman, Anke L., Jorne Lionel Biccler, Miriam Levi, et al.. (2023). Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe: results from the DRIVE multi-stakeholder study platform. Frontiers in Public Health. 11. 1195409–1195409. 9 indexed citations
4.
Baum, Ulrike, Eero Poukka, Tuija Leino, et al.. (2022). High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron. BMC Infectious Diseases. 22(1). 816–816. 32 indexed citations
5.
Baum, Ulrike, et al.. (2022). Feasibility assessment of patient-controlled EEG home-monitoring: More results from the HOMEONE study. Clinical Neurophysiology. 140. 12–20. 5 indexed citations
6.
Salo, Heini, Toni Lehtonen, Kari Auranen, Ulrike Baum, & Tuija Leino. (2022). Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinations. Vaccine. 40(24). 3345–3355. 8 indexed citations
7.
8.
Poukka, Eero, Ulrike Baum, Arto A. Palmu, et al.. (2021). Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021. Vaccine. 40(5). 701–705. 38 indexed citations
9.
Baum, Ulrike, Eero Poukka, Arto A. Palmu, et al.. (2021). Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill—An interim analysis of a nationwide cohort study. PLoS ONE. 16(11). e0258704–e0258704. 16 indexed citations
10.
Baum, Ulrike, Sangita Kulathinal, & Kari Auranen. (2021). Mitigation of biases in estimating hazard ratios under non-sensitive and non-specific observation of outcomes–applications to influenza vaccine effectiveness. Emerging Themes in Epidemiology. 18(1). 1–1. 5 indexed citations
11.
Baum, Ulrike, Sangita Kulathinal, & Kari Auranen. (2021). Exposure misclassification bias in the estimation of vaccine effectiveness. PLoS ONE. 16(5). e0251622–e0251622. 7 indexed citations
12.
Baum, Ulrike, H. Feistner, Michael Scholz, et al.. (2020). Eignung eines mobilen Trockenelektroden-EEG-Gerätes im Rahmen der Epilepsiediagnostik. Klinische Neurophysiologie. 51(3). 156–160. 6 indexed citations
13.
Neumann, Thomas, Ulrike Baum, H. Feistner, et al.. (2019). Assessment of the technical usability and efficacy of a new portable dry-electrode EEG recorder: First results of the HOMEONE study. Clinical Neurophysiology. 130(11). 2076–2087. 16 indexed citations
14.
15.
Baum, Ulrike, Mia Brytting, Niina Ikonen, et al.. (2017). Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 3 indexed citations
16.
Leino, Tuija, et al.. (2017). Impact of five years of rotavirus vaccination in Finland – And the associated cost savings in secondary healthcare. Vaccine. 35(42). 5611–5617. 24 indexed citations
17.
Baum, Ulrike, Tuija Leino, Mika Gissler, Terhi Kilpi, & Jukka Jokinen. (2015). Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: A cohort study of pregnancies stratified by trimester of vaccination. Vaccine. 33(38). 4850–4857. 31 indexed citations
18.
Baum, Ulrike. (2000). [Thiazolidinediones in type 2 diabetes].. PubMed. 23(7). 210–3. 3 indexed citations
19.
Schmitz-Moormann, P, G. W. Himmelmann, Ulrike Baum, & M Nilles. (1987). Morphological predictors of survival in colorectal carcinoma: Univariate and multivariate analysis. Journal of Cancer Research and Clinical Oncology. 113(6). 586–592. 19 indexed citations
20.
Rehfuess, K. E. & Ulrike Baum. (1980). Relations between the growth of Norway spruce (Picea abies) stands and chemical indices of their nitrogen supply.. Forstwissenschaftliches Centralblatt. 99(3). 146–154. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lennert Slobbe Breakdown of academic impact, for papers by Marco Bo Breakdown of academic impact, for papers by James L. Stewart Breakdown of academic impact, for papers by Meng Wu Breakdown of academic impact, for papers by Audrey Lustig Breakdown of academic impact, for papers by Daniel Jackson Breakdown of academic impact, for papers by Rebecca Rose Breakdown of academic impact, for papers by Renato Mendes Coutinho Breakdown of academic impact, for papers by Katie Frith
Rankless by CCL
2026